Cambridge-based Neurable are building a BCI cap for VR gaming.
Interaxon, makers of the Muse, raised 11.6M USD in a Series B-1 round led by Trend Forward Capital, Export Development Canada and OMERS Ventures.
This report from EdSurge surfaces good and bad around the BrainCo EEG/educations startup.
Brooklyn-based MindReader produce a bike helmet with various biosensors, including EEG, and an urban map of readings.
Regina Dugan is leaving her BCI-oriented role at Facebook's Building 8.
SF-based HVMN produce pills for "biohacking."
San Francisco-based Aurora AR plan to build AR goggles with "bio sensor input and analysis."
Essex-based Eyewink use ocular EMG to control smartphone apps with winks.
St Louis-based Neurolutions aim to build a BCI for stroke rehabilitation.
Pittsburgh-based Ebb market a prescription BCI device for treating insomnia.
Malmö-based Flow Neuroscience aim to treat depression with transcranial direct current stimulation (tDCS) to the forehead.
Lausanne- and Eindhoven-based GTherapeutics are developing an implantable neurostimulation device for spinal rehabilitation targeted at lower-limb paralysis.
MindMaze market a head-mounted display that detects emotions in VR.
SF- and Paris-based Rythm are building Dreem, an EEG-sensing headband for sleep.
NY-based CTRL-Labs are building a direct-control BCI.
LA- and Boston-based Kernel seem to be developing a neural implant.